Epidemiology of Tuberculosis and Drug Resistance in Tuberculosis Treatment in Indian Patients

Anti̇tüberküler Ajan Olarak N'-(2-(5-((Teofi̇li̇n-7-İl)meti̇l)-4-Eti̇l-1,2,4-Tri̇azol-3-İlti̇o)aceti̇l)i̇zoni̇koti̇nohi̇drazi̇t

“…Improper use of antimicrobials or ineffective dosage forms, as well as premature discontinuation of treatment can lead to the development of drug resistance [3][4][5][6][7][8].…”